The stock market indices had an up-day today, and a strong one, particularly by midday, making new all-time highs across the board. The day started out with a pop to the upside, a little pullback, and then they ran, the Nasdaq 100 going from 5197 to 5221, a new all-time high. In the afternoon, they came down to 5209, and bounced back to 5222, but couldn’t hold it, and backed off to 5212. The S&P 500 started out with a pop, and kept on running, reaching as high as 2320, a new all-time high, and backed off to 2307. All three indices came down slightly at the end of the day, but still closed in the green column.
Net on the day, the Dow was up 118.06 at 20,172.40. The S&P 500 was up 13.20 at 2307.87. The Nasdaq 100 was up 15.58 at 5212.16.
Advance-declines were 2 to 1 positive on the New York Stock Exchange, and 3 to 1 positive the Nasdaq. Up/down volume was 2 1/2 to 1 positive on New York, total volume of 3.6 billion shares traded. The Nasdaq traded 1.9 billion shares and had a 12 to 7 positive volume ratio.
TheTechTrader.com board was substantially higher for most today. Priceline.com (PCLN) was up 10.64 to 1611.83, Alphabet Inc. (GOOG) up 1.18 to 809.56, Apple Inc. (AAPL) up 94 cents to 132.41, Amazon.com, Inc. (AMZN) 1.65 to 821.36, but Netflix, Inc. (NFLX) dropped 60 cents to 144.14.
Baidu, Inc. (BIDU) closed flat at 181.50, Facebook, Inc. (FB) closed down 6 cents to 134.14, and First Solar, Inc. (FSLR) popped 68 cents to 32.23.
Tesla Motors, Inc. (TSLA) ran 7.12 to 269.20.
Other stocks to the upside included United States Steel Corp. (X) up 2.85 to 37.38, Shopify Inc. (SHOP) up 1.24 to 54.61, U.S. Concrete, Inc. (USCR) 1.00 to 64.25, and Twilio, Inc. (TWLO) 1.37 to 32.81.
Biotech’s were firm today with the Direxion Daily S&P Biotech Bull 3X ETF (LABU) up 2.24 to 44.23. Clovis Oncology Inc (CLVS) gained 1.72 to 65.13, although it reached a point and a half higher earlier in the day. Array BioPharma Inc. (ARRY) bounced 1.86 to 12.56,and Aerie Pharmaceuticals, Inc. (AERI) popped 1.60 to 46.40, reaching a new all-time high today. Both of these are swing trades.
On the downside, the were fractional losers for the most part, except for NVIDIA Corporation (NVDA), down 2.23 to 116.38.
Checking TheTechTrader.com percent-gain leaderboard, USA Technologies, Inc. (USAT) closed up 80 cents, or 21%, to 4.70.
Ignyta, Inc. (RXDX) ran 1.60, or 28%, to 7.35, on 1.3 million shares traded.
Aqua Metals, Inc. (AQMS) exploded 4.75, or 42%, to 16.16, on 3.5 million shares traded on a deal with Johnson Controls. SkyWest, Inc. (SKYW) advanced 2.20, or 6.6%, to 35.50. Acorda Therapeutics, Inc. (ACOR) bounced 4.25, or 21%, to 24.65, on 5.2 million shares traded. Cliffs Natural Resources Inc. (CLF) ran 1.85, or 19%, to 11.37, on 91 million shares traded. Insight Enterprises, Inc. (NSIT) rose 6.89, or 18 1/2%, to 44.17. OraSure Technologies, Inc. (OSUR) jumped 1.64, or 18 1/2%, to 10.49, on 4.8 million shares traded. Medidata Solutions, Inc. (MDSO) gained 7.80, or 16%, to 55.80, on 2.9 million shares traded.
Stepping back and reviewing the hourly chart patterns, the indices opened strong, ran in the morning, pulled back midday, rallied back in the afternoon, made nominal new highs, and backed off into the close. It was a very solid session.
Let’s see what happens tomorrow.
Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
EUR/USD trades weak below 1.0800 amid Good Friday lull, ahead of US PCE
EUR/USD remains depressed below 1.0800, as traders lack directional impetus amid minimal volatility and thin liquidity on Good Friday. The pair keenly awaits the US PCE inflation data and Fed Chair Powell's speech for fresh hints on next week's price action.
GBP/USD holds steady above 1.2600 as markets stay calm on Good Friday
GBP/USD trades sideways above 1.2600 amid a typical Good Friday trading lull. A broadly firmer US Dollar could keep any upside attempts limited in the pair ahead of the US PCE inflation data and Fed Chair Powell's appearance.
Gold ends Q1 2024 at record highs, what’s next?
Gold is sitting at an all-time high of $2,236, lacking a trading impetus amid holiday-thinned conditions on Good Friday. Most major world markets, including the United States are closed in observance of Holy Friday, leaving volatility around Gold price highly subdued.
Ripple's move above this key level could trigger nearly 50% rally for XRP
Ripple price has overcome a critical resistance level and flipped into a support floor on the weekly time frame. This development happened while XRP tightly consolidated for roughly 250 days.
US core PCE inflation set to ease in February on month as Federal Reserve rate cut bets for June mount
The core Personal Consumption Expenditures Price Index is set to rise 0.3% MoM and 2.8% YoY in February. The revised Summary of Projections showed that policymakers upwardly revised end-2024 core PCE forecast to 2.6% from 2.4%.